Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$379M |
| 2 |
Starbucks
SBUX
|
+$371M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$287M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$263M |
| 5 |
Tesla
TSLA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
ANDV
Andeavor
ANDV
|
+$1.11B |
| 3 |
AET
Aetna Inc
AET
|
+$535M |
| 4 |
Microsoft
MSFT
|
+$350M |
| 5 |
Amazon
AMZN
|
+$290M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.69% |
| 2 | Technology | 13.64% |
| 3 | Financials | 12.49% |
| 4 | Consumer Discretionary | 10.83% |
| 5 | Industrials | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PTR
1376
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $6.65M | 0.01% |
108,088
+1,120
| +1% | +$80.2K |
|
|
RSX
1377
DELISTED
VanEck Russia ETF
RSX
| $6.65M | 0.01% |
354,791
+273,018
| +334% | +$5.61M |
|
1378
MarketAxess Holdings
MKTX
$5.72B
| $6.63M | 0.01% |
+31,398
| New | +$6.5M |
|
1379
Fluor
FLR
$6.86B
| $6.63M | 0.01% |
206,003
+11,067
| +6% | +$477K |
|
1380
Regeneron Pharmaceuticals
REGN
$85.8B
| $6.62M | 0.01% |
17,735
-87,854
| -83% | -$32.2M |
|
1381
WisdomTree Japan Hedged Equity Fund
DXJ
$7.27B
| $6.62M | 0.01% |
+142,772
| New | +$7.45M |
|
1382
Galicia Financial Group
GGAL
$7.1B
| $6.61M | 0.01% |
239,793
+110,884
| +86% | +$2.82M |
|
1383
PUT
Albemarle
ALB
$15.7B
| $6.61M | 0.01% |
+85,700
| New | +$8.09M |
|
1384
Nomad Foods
NOMD
$1.66B
| $6.6M | 0.01% |
394,499
-1,225,693
| -76% | -$23.3M |
|
1385
Travere Therapeutics
TVTX
$6.32B
| $6.6M | 0.01% |
291,460
-228,159
| -44% | -$5.68M |
|
|
NPTN
1386
DELISTED
NEOPHOTONICS CORP
NPTN
| $6.59M | 0.01% |
1,017,235
-207,188
| -17% | -$1.58M |
|
1387
First Merchants
FRME
$2.61B
| $6.58M | 0.01% |
191,914
+40,909
| +27% | +$1.66M |
|
|
1388
Fortive
FTV
$18B
| $6.58M | 0.01% |
154,127
-26,962,802
| -99% | -$1.27B |
|
|
FISV
1389
Fiserv Inc
FISV
$27.9B
| $6.56M | 0.01% |
89,251
+84,251
| +1,685% | +$6.51M |
|
1390
NetEase
NTES
$82.5B
| $6.54M | 0.01% |
139,045
+108,170
| +350% | +$4.88M |
|
1391
Agnico Eagle Mines
AEM
$113B
| $6.53M | 0.01% |
+161,647
| New | +$5.95M |
|
|
SASR
1392
DELISTED
Sandy Spring Bancorp Inc
SASR
| $6.53M | 0.01% |
208,378
-149,732
| -42% | -$5.28M |
|
1393
BioCryst Pharmaceuticals
BCRX
$2.51B
| $6.52M | 0.01% |
808,027
-371,780
| -32% | -$2.89M |
|
1394
Five Below
FIVE
$14.3B
| $6.52M | 0.01% |
63,732
+37,773
| +146% | +$4.17M |
|
1395
CALL
NVIDIA
NVDA
$5.16T
| $6.51M | 0.01% |
1,952,000
+44,000
| +2% | +$211K |
|
1396
PUT
Viper Energy
VNOM
$15.8B
| $6.51M | 0.01% |
+250,000
| New | +$8.19M |
|
1397
TTM Technologies
TTMI
$11.8B
| $6.48M | 0.01% |
665,981
+578,650
| +663% | +$7.1M |
|
1398
Ciena
CIEN
$54.9B
| $6.47M | 0.01% |
190,842
-1,422,475
| -88% | -$45.1M |
|
|
ERF
1399
DELISTED
Enerplus Corporation
ERF
| $6.46M | 0.01% |
832,160
+606,316
| +268% | +$5.9M |
|
1400
Bread Financial
BFH
$4.14B
| $6.46M | 0.01% |
53,907
-76,470
| -59% | -$12M |
|
Similar funds
Israel Englander's Q4 2018 Portfolio in Review
As of Q4 2018, Israel Englander held 4,541 positions worth $64.1B, down 21% from $81.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander withdrew a net $4.25B in Q4 2018, closing 844 positions and reducing 1,571 holdings. Its most notable exit was Andeavor, an estimated $1.11B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Athenahealth, Inc. worth $135M.
- Israel Englander's largest Q4 2018 buy was Athenahealth, Inc.: 1,022,505 shares worth $135M.
- Israel Englander added most to Celgene Corp in Q4 2018, an estimated $379M increase.
- Israel Englander's biggest Q4 2018 reduction was Fortive, cutting an estimated $1.27B.
- Israel Englander fully exited Andeavor in Q4 2018, selling an estimated $1.11B.
- Israel Englander's ten largest holdings make up 6.7% of its $64.1B portfolio in Q4 2018.
- Israel Englander opened 702 new positions and closed 844 in Q4 2018.
- Israel Englander's portfolio value fell 21% quarter-over-quarter to $64.1B.
Based on Millennium Management's 13F filing for Q4 2018, filed 14 Feb 2019.